TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 93 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2016. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,985,000 | -7.9% | 950,000 | 0.0% | 0.27% | -9.3% |
| Q3 2017 | $6,498,000 | +30.6% | 950,000 | +36.1% | 0.30% | +19.5% |
| Q2 2017 | $4,977,000 | -22.4% | 698,000 | 0.0% | 0.25% | -32.2% |
| Q1 2017 | $6,415,000 | +128.0% | 698,000 | 0.0% | 0.37% | +96.8% |
| Q4 2016 | $2,813,000 | +10.9% | 698,000 | +5.4% | 0.19% | +18.2% |
| Q3 2016 | $2,537,000 | +38.8% | 662,500 | +55.9% | 0.16% | +17.8% |
| Q2 2016 | $1,828,000 | -1.3% | 425,000 | +6.2% | 0.14% | -12.9% |
| Q1 2016 | $1,852,000 | -7.7% | 400,000 | +100.0% | 0.16% | +2.0% |
| Q4 2015 | $2,006,000 | -1.7% | 200,000 | +365.1% | 0.15% | +2.0% |
| Q2 2015 | $2,040,000 | -45.7% | 43,000 | -58.0% | 0.15% | -57.5% |
| Q1 2015 | $3,756,000 | – | 102,500 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 664,000 | $2,543,000 | 0.82% |
| GREAT POINT PARTNERS LLC | 452,375 | $1,733,000 | 0.44% |
| Clearline Capital LP | 267,915 | $1,026,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,149,000,000 | 0.18% |
| Rock Springs Capital Management LP | 662,500 | $2,537,000 | 0.16% |
| Eventide Asset Management | 600,000 | $2,298,000 | 0.14% |
| Granahan Investment Management | 657,496 | $2,518,000 | 0.08% |
| Candriam S.C.A. | 374,000 | $1,432,000 | 0.03% |
| Tekla Capital Management LLC | 192,322 | $737,000 | 0.03% |
| DOW CHEMICAL CO /DE/ | 65,000 | $249,000 | 0.02% |